Association Between White Blood Cell Count, Epicardial Blood Flow, Myocardial Perfusion, and Clinical Outcomes in the Setting of Acute Myocardial Infarction: A Thrombolysis In Myocardial Infarction 10 Substudy
暂无分享,去创建一个
E. Braunwald | C. Cannon | S. Murphy | E. Braunwald | C. Gibson | H. Barron | C. Gibson
[1] C M Gibson,et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. , 2000, Circulation.
[2] Jeffrey M. Hausdorff,et al. Neutrophilia and congestive heart failure after acute myocardial infarction. , 2000, American heart journal.
[3] C. Cerletti,et al. Recent Advances in Platelet-Polymorphonuclear Leukocyte Interaction , 1999, Pathophysiology of Haemostasis and Thrombosis.
[4] M. Domanski,et al. White blood cell count and mortality in patients with ischemic and nonischemic left ventricular systolic dysfunction (an analysis of the Studies Of Left Ventricular Dysfunction [SOLVD]) , 1999, The American journal of cardiology.
[5] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[6] E. Braunwald,et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. , 1999, Circulation.
[7] R. Giugliano,et al. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. , 1998, Circulation.
[8] F. Neumann,et al. Procoagulant inflammatory responses of monocytes after direct balloon angioplasty in acute myocardial infarction. , 1998, The American journal of cardiology.
[9] P. Ridker,et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. , 1998, Circulation.
[10] H. White,et al. Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected Thrombolysis in Myocardial Infarction (TIMI) frame count and stenosis severity. , 1998, The American journal of cardiology.
[11] J. Dodge,et al. Thrombolysis in Myocardial Infarction frame count in saphenous vein grafts. , 1998, American heart journal.
[12] F. Neumann,et al. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[13] S. Ogawa,et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. , 1997, Circulation.
[14] F. Neumann,et al. Induction of cytokine expression in leukocytes in acute myocardial infarction. , 1997, Journal of the American College of Cardiology.
[15] P. Ridker,et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.
[16] L. Horwitz,et al. An antibody to leukocyte integrins attenuates coronary vascular injury due to ischemia and reperfusion in dogs. , 1997, The American journal of physiology.
[17] E. Braunwald,et al. TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial. , 1997, Circulation.
[18] R. Goldberg,et al. Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. , 1996, The American journal of cardiology.
[19] T. Springer,et al. Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. , 1996, Blood.
[20] E. Braunwald,et al. TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.
[21] S. Berliner,et al. Increased adhesiveness of peripheral blood leukocytes corresponds to the appearance of expansion following anterior wall myocardial infarction , 1996, Clinical cardiology.
[22] F. Neumann,et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. , 1995, Circulation.
[23] D. Mann,et al. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. , 1994, Chest.
[24] T Sandor,et al. Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials. , 1992, The American journal of cardiology.
[25] M. Burr,et al. Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). , 1992, European heart journal.
[26] A. M. Lefer,et al. Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. , 1991, The Journal of clinical investigation.
[27] R. Kloner,et al. Influx of Neutrophils Into the Walls of Large Epicardial Coronary Arteries in Response to Ischemia/Reperfusion , 1991, Circulation.
[28] P C Elwood,et al. Fibrinogen, Viscosity, and White Blood Cell Count Are Major Risk Factors for Ischemic Heart Disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies , 1991, Circulation.
[29] J. Dormandy,et al. Leukocytes and the risk of ischemic diseases. , 1987, JAMA.
[30] C. Forbes,et al. White Blood Cell Count and Haematocrit as Predictors of Coronary Recurrence after Myocardial Infarction , 1985, Thrombosis and Haemostasis.
[31] W. Ganz,et al. The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.
[32] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.
[33] G. Schmid-Schönbein,et al. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. , 1983, The American journal of pathology.
[34] R. Kloner,et al. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. , 1974, The Journal of clinical investigation.